Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40765091	cv-kromos	— (—)	170	181	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Maternal care for known or suspected fetal abnormality and damage

117

127.65

103.56

1.1

1.3

—

Spontaneous abortion

27.75

85.42

1.1

—

Medical abortion

22.28

71.12

1.0

1.1

—

Procreative management

+∞

68.94

1.0

0.0

—

Other abnormal products of conception

20.27

56.88

1.0

1.1

—

Pregnancy with abortive outcome

18.55

56.49

1.1

—

Maternal care for other known or suspected fetal problems

26.04

41.92

1.0

1.2

—

Abnormal findings on antenatal screening of mother

8.91

30.68

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

18.69

30.50

1.1

1.2

—

Follow-up examination after treatment for conditions other than malignant neoplasms

7.03

29.25

1.0

1.1

—

Supervision of high-risk pregnancy

+∞

24.55

1.1

0.0

—

Postpartum care and examination

+∞

24.24

1.0

0.0

—

Family history of certain disabilities and chronic diseases leading to disablement

21.63

22.13

1.0

1.1

—

Pregnancy examination and test

+∞

21.46

1.0

0.0

—

Maternal care for known or suspected abnormality of pelvic organs

27.28

21.15

1.0

1.3

—

Haemorrhage in early pregnancy

5.92

19.08

1.1

—

Other maternal disorders predominantly related to pregnancy

4.59

17.76

1.0

1.1

—

Antenatal screening

+∞

17.23

1.1

0.0

—

Premature rupture of membranes

23.30

16.88

1.1

1.3

—

Diabetes mellitus in pregnancy

4.47

16.34

1.0

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

105

3.47

14.56

1.0

1.1

—

Gestational diabetes (for exclusion)

110

3.36

13.42

1.0

1.1

—

Female infertility

3.93

12.60

1.1

1.0

—

False labour

14.36

12.42

1.0

1.2

—

Prolonged pregnancy

18.62

11.14

1.1

1.3

—

Outcome of delivery

+∞

11.13

1.2

0.0

—

Female infertility, cervical, vaginal, other or unspecified origin

3.83

11.04

1.2

1.0

—

Personal history of other diseases and conditions

7.99

11.01

1.0

1.1

—

Medical treatment for female infertility

3.59

10.92

1.1

1.0

—

Persons encountering health services in circumstances related to reproduction

+∞

10.66

1.1

0.0

—

Maternal care for known or suspected malpresentation of fetus

15.42

9.97

1.0

1.3

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

109

2.92

9.95

1.0

1.1

—

Habitual aborter

20.29

9.82

1.1

1.0

—

Other obstetric conditions, not elsewhere classified

109

2.86

9.47

1.0

1.1

—

Chromosomal abnormalities, not elsewhere classified

24.24

8.91

1.2

1.0

—

Single delivery by caesarean section

5.75

8.80

1.0

—

Pregnancy, childbirth and the puerperium

+∞

8.73

1.1

0.0

—

Maternal care for other conditions predominantly related to pregnancy

3.93

8.50

1.1

—

Twin gestation

20.05

8.46

1.1

1.2

—

Multiple gestation

20.05

8.46

1.1

1.2

—

Other complications of labour and delivery, not elsewhere classified

3.56

7.31

1.1

—

Contraceptive management

+∞

7.23

1.0

0.0

—

Postpartum haemorrhage

3.16

6.74

1.1

—

Balanced rearrangements and structural markers, not elsewhere classified

+∞

6.29

1.3

0.0

—

Other disorders of amniotic fluid and membranes

12.22

5.99

1.0

1.3

—

Supervision of normal pregnancy

+∞

4.96

1.0

0.0

—

Delivery

3.77

4.18

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

2.56

3.87

1.1

—

Ectopic pregnancy

12.01

3.76

1.2

—

Noninflammatory disorders of female genital tract

2.26

3.72

1.1

1.0

—

Labour and delivery complicated by fetal stress [distress]

2.37

3.72

1.1

—

Single spontaneous delivery

3.53

3.62

1.1

1.0

—

Maternal care for cervical incompetence

7.81

3.56

1.0

1.1

—

Benzodiazepine use

158

0.30

3.41

1.0

1.1

—

Antepartum haemorrhage, not elsewhere classified

8.58

3.26

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

136

2.03

3.17

1.1

—

Failed induction of labour

3.68

3.08

1.0

1.1

—

Antihypertensive medication - note that there are other indications

154

0.34

3.05

1.0

1.1

—

Nerve, nerve root and plexus disorders

134

0.32

3.04

1.0

1.1

—

Multiple delivery

5.84

3.02

1.0

—

Postpartum hemorraghe, all women as controls

132

2.02

2.93

1.1

—

Pre-eclampsia or poor fetal growth

127

2.04

2.93

1.0

1.1

—

Complications of labour and delivery

2.08

2.91

1.0

1.1

—

Preterm labour and delivery

2.83

2.91

1.1

—

Retained placenta and membranes, without haemorrhage

4.10

2.88

1.1

—

Female infertility, associated with anovulation

2.77

2.81

1.0

1.1

—

Caries of enamel

127

1.87

2.78

1.1

—

3.58

2.78

1.0

1.1

—

Hyperkinetic disorders, excluding more controls

0.00

2.76

0.0

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

141

0.34

2.73

1.0

1.1

—

Single delivery by forceps and vacuum extractor

3.49

2.72

1.1

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

140

1.91

2.70

1.1

1.0

—

Atopic dermatitis

132

1.86

2.56

1.0

1.1

—

Other problems related to primary support group, including family circumstances

3.06

2.55

1.2

1.1

—

Perineal laceration during delivery

2.21

2.54

1.1

—

Obesity, other/unspecified

2.16

2.50

1.1

—

Fall on same level

158

0.41

2.47

1.0

1.1

—

Use of hypnotics and sedatives

120

0.38

2.40

1.0

1.1

—

Persons encountering health services for examination and investigation

2.11

2.25

1.0

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

145

0.42

2.25

1.1

—

Hyperkinetic disorders

0.00

2.25

0.0

1.1

—

Disturbance of activity and attention

0.00

2.24

0.0

1.1

—

Poor fetal growth

2.13

2.18

1.1

—

Inflammatory diseases of female pelvic organs

136

1.73

2.16

1.1

—

Pain in limb

142

0.42

2.13

1.0

1.1

—

Labour and delivery complicated by umbilical cord complications

4.01

2.04

1.0

1.2

—

Any event in cancer register

124

0.43

2.04

1.0

1.1

—

Examination and observation for other reasons

2.08

1.98

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.35

1.96

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.72

1.95

1.0

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

0.34

1.95

1.0

1.1

—

Other coagulation defects

3.75

1.93

1.0

1.1

—

Open wound of head

0.00

1.88

0.0

1.1

—

Other female pelvic inflammatory diseases

2.65

1.86

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

2.86

1.86

1.0

1.1

—

Postpartum haemorrhage due to anatomy

100

1.90

1.85

1.1

—

All kidney diseases

154

0.44

1.84

1.0

1.1

—

Phlebitis and thrombophlebitis (not including DVT)

3.53

1.83

1.0

1.1

—

Abnormalities of forces of labour

3.05

1.80

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

132

1.68

1.78

1.0

1.1

—

Other bacterial diseases

116

0.44

1.75

1.0

1.1

—

Renal tubulo-interstitial diseases

135

0.44

1.72

1.0

1.1

—

Influenza and pneumonia

156

0.49

1.70

1.1

—

Other diseases of intestines

155

0.51

1.70

1.0

1.1

—

All pneumoniae

145

0.46

1.68

1.1

—

Injuries to the head

157

0.51

1.64

1.1

—

Diabetes, varying definitions

134

0.48

1.63

1.0

1.1

—

Finngen Rheumatological endpoints

144

0.51

1.59

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

110

0.44

1.59

1.3

1.1

—

Postpartum hemorraghe, parous women as controls

141

1.63

1.58

1.1

—

Other nutritional deficiencies

142

1.66

1.58

1.1

—

Puerperal sepsis

3.00

1.58

1.0

1.1

—

Rotator cuff syndrome

0.00

1.56

0.0

1.1

—

Other soft tissue disorders, not elsewhere classified

147

0.52

1.56

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

128

0.48

1.54

1.1

—

Acute pharyngitis

0.00

1.52

0.0

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

1.52

0.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

132

1.60

1.52

1.0

1.1

—

Gingivitis and periodontal diseases

1.62

1.48

1.1

1.0

—

Polyarthropathies

0.43

1.44

1.2

1.1

—

Abnormalities of breathing

134

0.52

1.44

1.1

—

Persons encountering health services in other circumstances, wide

1.58

1.42

1.0

1.1

—

Dizziness and giddiness

100

0.40

1.38

1.0

1.1

—

Injuries to the knee and lower leg

154

0.58

1.36

1.2

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

103

0.51

1.35

1.0

1.1

—

Functional dyspepsia

0.00

1.33

0.0

1.1

—

Genitourinary diseases

1.87

1.33

1.1

1.0

—

Long labour

1.83

1.33

1.1

—

Other bacterial diseases

0.44

1.32

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

0.45

1.31

1.3

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

119

0.51

1.31

1.1

—

119

0.51

1.31

1.1

—

Dermatitis and eczema

132

1.50

1.31

1.0

1.1

—

Cardiac arrhythmias

106

0.49

1.28

1.1

—

Hallux valgus (acquired)

2.54

1.27

1.2

1.1

—

Obesity

140

1.59

1.27

1.1

—

Diseases of oesophagus, stomach and duodenum

124

0.53

1.27

1.0

1.1

—

Obesity and other hyperalimentation

140

1.58

1.26

1.1

—

Explicit Sepsis

2.05

1.26

1.0

1.1

—

Type 2 diabetes, definitions combined

101

0.52

1.23

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

101

0.52

1.23

1.0

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

134

1.56

1.22

1.0

1.1

—

Other specific joint derangements/joint disorders

140

0.55

1.22

1.1

—

Dentofacial anomalies [including malocclusion]

143

1.52

1.22

1.0

1.1

—

Intracranial trauma

122

0.52

1.21

1.0

1.1

—

Dysplasia of cervi uteri

1.78

1.19

1.1

1.0

—

Pre-eclampsia

1.83

1.19

1.0

1.1

—

Excessive vomiting in pregnancy

2.31

1.18

1.0

—

Hard cardiovascular diseases

0.00

1.18

0.0

1.1

—

Other diseases of hard tissues of teeth

1.86

1.17

1.1

1.0

—

Venous thromboembolism

2.09

1.17

1.0

1.1

—

Inflammatory disease of uterus

1.93

1.16

1.0

1.1

—

Diabetes mellitus

132

0.58

1.15

1.0

1.1

—

Infections of breast associated with childbirth

2.50

1.15

1.0

1.1

—

Artrosis, including avohilmo

0.48

1.14

1.0

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.72

1.14

1.1

—

Pregnancy hypertension

134

1.54

1.13

1.0

1.1

—

Disorders of synovium and tendon

100

0.44

1.13

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

105

0.54

1.12

1.1

—

Soft tissue disorders

147

0.63

1.11

1.1

—

Leiomyoma of uterus

0.44

1.05

1.0

1.1

—

Disorders of tooth development and eruption

1.97

1.04

1.1

1.0

—

Adenomyosis (Endometriosis of uterus)

2.27

1.03

1.0

1.1

—

Lumbar disc prolapse

0.47

1.02

1.0

1.1

—

Pre-eclampsia or eclampsia

1.73

1.02

1.0

1.1

—

Persons encountering health services for specific procedures and health care

145

0.62

1.02

1.0

1.1

—

Other intervertebral disc disorders

0.56

1.02

1.0

1.1

—

STROKE

0.00

1.00

0.0

1.1

—

Cerebrovascular diseases

0.00

0.99

0.0

1.1

—

Neurological diseases

139

0.65

0.98

1.0

1.1

—

Acetic acid derivatives and related substances

1.87

0.98

1.1

1.2

—

Other viral diseases, not elsewhere classified

0.00

0.97

0.0

1.1

—

Other puerperal infections

1.80

0.96

1.0

1.1

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.96

0.0

1.1

—

Implicit Sepsis

0.51

0.96

1.3

1.1

—

Cholelithiasis, broad definition with cholecystitis

100

0.54

0.95

1.1

—

Other enthesopathies

0.00

0.95

0.0

1.1

—

Type 2 diabetes

117

0.60

0.95

1.0

1.1

—

Other sexually transmitted chlamydial diseases

1.77

0.94

1.1

1.0

—

Codeine or tramadol medication

149

0.66

0.93

1.0

1.1

—

Codeine

141

0.65

0.92

1.0

1.1

—

Diabetes medication

132

0.63

0.92

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

131

1.41

0.90

1.0

1.1

—

Infections of genitourinary tract in pregnancy

2.07

0.89

1.2

1.1

—

Headache

136

0.59

0.89

1.0

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

1.70

0.88

1.0

1.1

—

Mycoses

146

1.43

0.88

1.0

1.1

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.86

0.87

1.0

1.1

—

Pain in joint

0.57

0.86

1.1

—

Ovarian cyst

1.56

0.85

1.0

—

Hernia

0.56

0.85

1.1

—

Cholelithiasis

0.57

0.85

1.1

—

Substance abuse, excluding more controls

0.53

0.83

1.0

1.1

—

Major coronary heart disease event

0.00

0.82

0.0

1.1

—

Superficial injury of wrist and hand

1.74

0.82

1.1

—

Impacted maxillary molar

1.88

0.81

1.0

1.1

—

Umbilical hernia

1.88

0.81

1.2

1.1

—

Other (not insulin) diabetes medications

0.60

0.81

1.0

1.1

—

Other heart diseases, wide

124

0.64

0.80

1.1

—

Other disorders of ear

0.57

0.80

1.1

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.79

0.0

1.1

—

Other noninflammatory disorders of vulva and perineum

0.00

0.79

0.0

1.0

—

Complications predominantly related to the puerperium

114

1.49

0.79

1.1

—

Other sexually transmitted chlamydial diseases

1.82

0.79

1.2

1.1

—

Type 1 diabetes, strict definition

0.00

0.79

0.0

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

141

0.67

0.78

1.0

1.1

—

Diseases of the eye and adnexa

137

0.69

0.78

1.1

—

Infections with a predominantly sexual mode of transmission

145

1.41

0.78

1.0

1.1

—

Lyme disease

0.00

0.78

0.0

1.1

—

Spirochaetal infections, other/unspecified

0.00

0.77

0.0

1.1

—

Other spirochaetal diseases

0.00

0.77

0.0

1.1

—

Other spirochaetal diseases

0.00

0.77

0.0

1.1

—

Necrosis of pulp, including avohilmo

124

0.56

0.77

1.0

1.1

—

Intestinal infectious diseases

144

1.37

0.76

1.0

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.77

0.76

1.0

1.1

—

Leisure time condition

0.00

0.76

0.0

1.1

—

General symptoms and signs

136

0.70

0.76

1.1

—

Infections with a predominantly sexual mode of transmission

115

1.48

0.76

1.1

—

Aplastic and other anaemias

2.12

0.75

1.0

1.1

—

Gestational [pregnancy-induced] hypertension

116

1.46

0.73

1.0

1.1

—

Other disorders of veins

1.83

0.73

1.0

1.1

—

Low back pain

132

0.65

0.71

1.1

—

Sleep disorders

139

1.35

0.71

1.0

1.1

—

Concussion

117

0.63

0.70

1.0

1.1

—

Other joint disorders

140

0.72

0.69

1.1

—

Special screening examination for infectious and parasitic diseases

1.62

0.69

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

118

0.59

0.67

1.1

—

Disorders of skin appendages

119

0.59

0.67

1.1

—

Dyspnoea

115

0.64

0.65

1.0

1.1

—

Car occupant injured in other and unspecified transport accidents

1.59

0.65

1.0

1.1

—

Other disorders of lacrimal gland

1.59

0.65

1.1

—

Asthma/COPD (KELA code 203)

147

0.70

0.64

1.1

—

Episodal and paroxysmal disorders

145

0.74

0.64

1.0

1.1

—

Acute tubulo-interstitial nephritis

110

0.63

0.64

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

126

0.63

1.1

—

Other arrhythmias

0.57

0.63

1.2

1.1

—

Psychiatric diseases

113

0.71

0.62

1.0

1.1

—

Propionic acid derivatives

1.61

0.62

1.0

1.2

—

Percutaneous Coronary Intervention

0.00

0.62

0.0

1.1

—

Coronary revascularization (ANGIO or CABG)

0.00

0.62

0.0

1.1

—

Emergency coronary revascularization (for ACS)

0.00

0.61

0.0

1.1

—

Cerebrovascular diseases (FINNGEN)

0.00

0.61

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

129

0.64

0.60

1.2

1.1

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.60

0.0

1.1

—

Noninfectious colitis NAS

0.00

0.60

0.0

1.1

—

Atrophic disorders of skin

0.00

0.60

0.0

1.1

—

Speech therapy

0.00

0.60

0.0

1.1

—

GI-bleeding

0.00

0.60

0.0

1.1

—

Other diseases of the digestive system

0.00

0.60

0.0

1.1

—

Complications of the puerperium, not elsewhere classified

0.00

0.60

0.0

1.0

—

Biguanides

0.66

0.59

1.0

1.1

—

MS-disease / Multiple Sclerosis

0.00

0.59

0.0

1.1

—

Melanocytic naevi of trunk

0.00

0.59

0.0

1.1

—

Spondylosis

0.00

0.59

0.0

1.1

—

Candidiasis

1.53

0.59

1.0

1.1

—

Iron deficiency anaemia

1.52

0.58

1.0

1.1

—

Lower back pain or/and sciatica

152

0.73

0.58

1.1

—

Menorrhagia

0.54

0.58

1.2

1.0

—

Schizophrenia

0.00

0.58

0.0

1.1

—

Sequelae of external causes of morbidity and mortality

0.00

0.58

0.0

1.1

—

Other medical care

1.69

0.57

1.0

1.1

—

Depression or dysthymia

0.63

0.57

1.0

1.1

—

Autoimmune diseases related-to ILD

148

0.69

0.57

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.46

0.56

1.0

1.1

—

Other acute lower respiratory infections

0.57

0.56

1.0

1.1

—

Any reimbursement code in KELA

122

0.74

0.56

1.1

—

Disorders of sclera, cornea, iris and ciliary body

0.57

0.56

1.2

1.1

—

Open wound of wrist and hand

0.56

1.0

1.1

—

Contact with and exposure to communicable diseases

132

1.36

0.55

1.1

—

Tramadol

0.67

0.55

1.1

—

Mycoses

1.62

0.55

1.0

1.1

—

Exposure to other specified factors

147

0.69

0.55

1.2

1.1

—

Polycystic ovarian syndrome, consortium definition

150

0.75

0.55

1.0

1.1

—

Other antidepressants

124

0.74

0.54

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

133

0.72

0.53

1.1

—

Melanocytic naevi

1.43

0.52

1.0

—

Mental and behavioural disorders due to psychoactive substance use

0.61

0.52

1.0

1.1

—

Polycystic ovarian syndrome, broad definition

1.45

0.51

1.0

1.1

—

Other headache syndromes

100

0.60

0.51

1.0

1.1

—

Depression medications

0.69

0.51

1.0

1.1

—

Deforming dorsopathies

1.46

0.50

1.0

1.1

—

Insomnia

143

1.27

0.50

1.0

1.1

—

Chronic apical periodontitis

148

0.77

0.50

1.1

—

Asthma, unspecified (mode)

0.64

0.49

1.1

—

Asthma, unspecified (mode), excluding more controls

0.64

0.49

1.1

—

Injuries to the shoulder and upper arm

0.63

0.49

1.0

1.1

—

Childhood allergy (age < 16)

1.41

0.48

1.0

1.1

—

Neurological diseases, wide definition

0.69

0.48

1.0

1.1

—

Gastrointestinal diseases

107

0.75

0.47

1.0

1.1

—

Disorders of thyroid, IBD co-morbidities

0.60

0.46

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

144

1.30

0.46

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

128

0.77

0.45

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

106

0.76

0.45

1.0

1.1

—

Persons with potential health hazards related to communicable diseases

137

1.30

0.44

1.1

—

Asthma and allergy, excluding more controls

1.38

0.44

1.0

1.1

—

Fenamates

1.62

0.43

1.2

—

Disorders of breast

119

0.69

0.43

1.0

1.1

—

Conjunctivitis

155

0.75

0.43

1.0

1.1

—

Oral corticosteroids

137

0.78

0.42

1.1

—

Cholecystectomy

0.62

0.42

1.2

1.0

—

Disorders of other endocrine glands

0.63

0.42

1.0

1.1

—

Transient ischemic attack

0.00

0.41

0.0

1.0

—

Ischaemic Stroke, excluding all haemorrhages

0.00

0.41

0.0

1.0

—

Periodontitis

101

0.73

0.41

1.0

1.1

—

Mandibular retrognathia

0.00

0.41

0.0

1.1

—

Hypertrophic scar

0.00

0.41

0.0

1.1

—

Fracture of lumbar spine and pelvis

0.00

0.41

0.0

1.1

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.41

0.0

1.1

—

Pain associated with micturition

0.00

0.41

0.0

1.1

—

Other/unspecified synovitis and tenosynovitis

0.00

0.41

0.0

1.1

—

Psoriatic and enteropathic arthropathies

0.00

0.41

0.0

1.1

—

Diplopia

0.00

0.41

0.0

1.1

—

Other diseases of liver

0.00

0.41

0.0

1.1

—

Intestinal stricture

0.00

0.41

0.0

1.0

—

Glaucoma suspect

0.00

0.41

0.0

1.1

—

Schizoaffective disorder

0.00

0.41

0.0

1.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.41

0.0

1.1

—

Malignant neoplasm of skin

0.00

0.40

0.0

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.40

0.0

1.1

—

Perforation of tympanic membrane

0.00

0.40

0.0

1.1

—

Infective dermatitis

0.00

0.40

0.0

1.1

—

Heartburn

0.00

0.40

0.0

1.2

—

Restless leg syndrome

0.00

0.40

0.0

1.1

—

Abnormal involuntary movements

0.00

0.40

0.0

1.1

—

Sequelae with surgical and medical care as external cause

0.00

0.40

0.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.40

0.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

0.00

0.40

0.0

1.1

—

Superficial injury of hip and thigh

0.00

0.40

0.0

1.1

—

Haemorrhage from respiratory passages

0.00

0.40

0.0

1.1

—

Stroke, excluding SAH

0.00

0.40

0.0

1.0

—

Liquid cancers, helper endpoint

0.00

0.40

0.0

1.1

—

Stroke, including SAH

0.00

0.40

0.0

1.0

—

Nutritional anaemias

1.33

0.40

1.0

1.1

—

Open bite

0.00

0.40

0.0

1.1

—

Hypertrophic disorders of skin

0.00

0.40

0.0

1.1

—

Rosacea

0.00

0.40

0.0

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.43

0.39

1.0

1.1

—

Heterophoria

0.00

0.39

0.0

1.1

—

Benign lipomatous neoplasm

0.00

0.39

0.0

1.1

—

Chronic periodontitis, including avohilmo

100

0.74

0.39

1.0

1.1

—

Disorders of conjunctiva

155

0.78

0.38

1.0

1.1

—

Any mental disorder

125

0.80

0.38

1.0

1.1

—

Dental caries, including avohilmo

1.32

0.38

1.1

—

Parasetamol

103

1.23

0.38

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

116

1.25

0.38

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

139

1.22

0.37

1.0

1.1

—

Selective serotonin reuptake inhibitors

124

0.80

0.37

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

112

0.71

0.37

1.0

1.1

—

Anxiety disorders, excluding more controls

125

0.78

0.36

1.0

1.1

—

Falls/tendency to fall

146

0.82

0.36

1.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.32

0.36

1.1

—

Implicit Sepsis

0.62

0.36

1.4

1.1

—

Acute upper respiratory infections

127

1.21

0.35

1.1

—

Hernia of abdominal wall

1.40

0.35

1.2

1.1

—

Cutaneous abscess, furuncle and carbuncle

1.36

0.34

1.0

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

143

0.80

0.34

1.1

—

Diseases of the musculoskeletal system and connective tissue

101

0.79

0.33

1.1

—

Endometriosis of pelvic peritoneum

1.33

0.33

1.0

—

Gastro-oesophageal reflux disease

0.69

0.33

1.0

1.1

—

Sulfasalazine

1.30

0.33

1.3

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

1.41

0.33

1.0

1.2

—

Substance abuse

0.66

0.32

1.0

1.1

—

Tonsillectomy and adenotomy

139

1.20

0.32

1.0

1.1

—

Chronic lower respiratory diseases

147

0.83

0.32

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.30

0.32

1.0

1.1

—

Dental pulpitis, including avohilmo

142

1.19

0.31

1.0

1.1

—

Other anxiety disorders

143

0.79

0.31

1.0

1.1

—

Asthma and allergy

1.35

0.31

1.0

1.1

—

Appendectomy

140

1.23

0.31

1.1

—

Injuries to the ankle and foot

156

0.80

0.31

1.1

—

LSIL lesion of the cervix uteri

1.32

0.30

1.1

—

Disorders of lacrimal system

1.32

0.30

1.1

—

Second line medication for Crohn's disease

100

0.70

0.30

1.1

—

Allergic conjunctivitis

149

0.78

0.30

1.0

1.1

—

Dorsalgia

135

0.83

0.30

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.24

0.29

1.0

1.1

—

Covid-19 confirmed case

1.25

0.29

1.0

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

119

1.25

0.29

1.1

—

Osteopathies and chondropathies

1.23

0.29

1.1

—

Inflammatory bowel disease treatment related agents

146

0.84

0.28

1.1

—

Disease of hard tissues of teeth, NOS

1.34

0.28

1.0

—

ILD medications: immunosuppressive drugs

110

0.76

0.27

1.1

—

Autoimmune diseases excluding thyroid diseases

130

0.84

0.27

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

146

0.80

0.27

1.0

1.1

—

Atopic dermatitis, strict definition

111

1.24

0.26

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.32

0.26

1.0

—

Other and unspecified effects of external causes

0.67

0.25

1.4

1.1

—

Pain in throat and chest

116

0.83

0.25

1.1

—

Disorders of eyelid, lacrimal system and orbit

105

0.80

0.25

1.1

—

Other reaction to severe stress, and adjustment disorders

123

1.22

0.25

1.1

—

Atopic dermatitis, strict definition with reimbursement

110

1.23

0.25

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

113

0.84

0.25

1.0

1.1

—

Asthma (diagnoses ohter than nonallergic)

150

0.83

0.24

1.1

—

Certain infectious and parasitic diseases

117

1.16

0.24

1.0

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.18

0.24

1.1

—

Neoplasms

134

1.15

0.24

1.0

1.1

—

Reimbursement for rheumatic diseases

1.16

0.24

1.2

1.0

—

Diseases of middle ear and mastoid

147

1.17

0.23

1.0

1.1

—

Intestinal infectious diseases

129

1.15

0.23

1.1

—

Obesity related asthma

1.32

0.23

1.2

1.1

—

Post-traumatic stress disorder

1.28

0.23

1.0

1.1

—

Migraine

145

0.84

0.22

1.0

1.1

—

Migraine without aura

0.75

0.22

1.0

1.1

—

Acne

1.25

0.22

1.0

1.1

—

Dermatitis

0.74

0.22

1.0

1.1

—

0.73

0.22

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

142

0.87

0.22

1.0

1.1

—

Caries of dentine, including avohilmo

1.20

0.22

1.1

—

Basal cell carcinoma, including avohilmo

0.00

0.22

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

0.00

0.22

0.0

1.0

—

Abdominal and pelvic pain

106

0.85

0.21

1.0

1.1

—

Hirsutism in women

0.00

0.21

0.0

1.1

—

Hypertrichosis

0.00

0.21

0.0

1.1

—

Astigmatism

0.00

0.21

0.0

1.1

—

Anankastic personality disorder

0.00

0.21

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

0.21

0.0

1.1

—

Cluster headache, strict, including avohilmo

0.00

0.21

0.0

1.0

—

Hyperfunction of pituitary gland

0.00

0.21

0.0

1.1

—

Asthma mixed form (mode), excluding more controls

0.00

0.21

0.0

1.1

—

Cluster headache, wide,, including avohilmo

0.00

0.21

0.0

1.0

—

Contusion of other and unspecified parts of foot

0.00

0.21

0.0

1.1

—

Asthma mixed form (mode)

0.00

0.21

0.0

1.1

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

Viral infections of the central nervous system

0.00

0.21

0.0

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

0.21

0.0

1.0

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.0

—

Sequelae of infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

Unknown and unspecified causes of morbidity

0.00

0.21

0.0

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

0.21

0.0

1.0

—

Nail disorders

0.00

0.21

0.0

1.1

—

Abnormal results of function studies

0.00

0.21

0.0

1.1

—

Weight loss

0.00

0.21

0.0

1.2

—

Seborrhoeic dermatitis

0.00

0.21

0.0

1.0

—

Other and unspecified visual disturbances

0.00

0.21

0.0

1.0

—

Plantar fascial fibromatosis

0.00

0.21

0.0

1.0

—

Hydronephrosis

0.00

0.21

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

0.21

0.0

1.0

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

1.0

—

Rheumatism, unspecified

0.00

0.21

0.0

1.0

—

Lateral epicondylitis

0.00

0.21

0.0

1.0

—

Trochanteric bursitis

0.00

0.21

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

0.21

0.0

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

0.00

0.21

0.0

1.1

—

Fibroblastic disorders

0.00

0.21

0.0

1.0

—

Chronic gastritis

0.00

0.21

0.0

1.0

—

Abnormal serum enzyme levels

0.00

0.21

0.0

1.1

—

Agoraphobia

0.00

0.21

0.0

1.1

—

Radial styloid tenosynovitis [de Quervain]

0.00

0.21

0.0

1.1

—

Other and unspecified injuries of lower leg

0.00

0.21

0.0

1.1

—

Metatarsalgia

0.00

0.21

0.0

1.1

—

Use of pramipexole

0.00

0.21

0.0

1.0

—

Symptoms and signs concerning food and fluid intake

0.00

0.21

0.0

1.2

—

Presence of other devices

0.00

0.21

0.0

1.1

—

Acute nasopharyngitis (common cold)

0.00

0.21

0.0

1.1

—

Embedded and impacted teeth

119

1.18

0.21

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

104

0.77

0.21

1.0

1.1

—

Fitting and adjustment of other devices

0.00

0.21

0.0

1.0

—

Etanercept

0.00

0.21

0.0

1.0

—

Viral infections of the central nervous system

0.00

0.21

0.0

1.1

—

Other peripheral vascular diseases

0.00

0.21

0.0

1.0

—

Other and unspecified rosacea

0.00

0.21

0.0

1.0

—

Other complications of surgical and medical care, not elsewhere classified

0.00

0.21

0.0

1.0

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.21

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.21

0.0

1.1

—

Paralytic ileus and intestinal obstruction

0.00

0.21

0.0

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.00

0.21

0.0

1.0

—

COPD/asthma/ILD related infections

119

1.14

0.20

1.1

—

COPD/asthma related infections

119

1.14

0.20

1.1

—

Opioids

142

0.88

0.20

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

0.00

0.20

0.0

1.1

—

Mood disorders, excluding more controls

125

0.86

0.20

1.0

1.1

—

Excessive, frequent and irregular menstruation

0.81

0.20

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

139

1.17

0.20

1.0

1.1

—

Cerebral cysts

0.00

0.20

0.0

1.1

—

Other viral hepatitis

0.00

0.20

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.20

0.0

1.1

—

Viral hepatitis, IBD co-morbidity

0.00

0.20

0.0

1.1

—

Viral hepatitis

0.00

0.20

0.0

1.0

—

Benign neoplasm of bone and articular cartilage

0.00

0.20

0.0

1.0

—

Open wound of forearm

0.00

0.20

0.0

1.1

—

Burns and corrosions of external body surface, specified by site

0.00

0.20

0.0

1.0

—

Bell's palsy

0.00

0.20

0.0

1.1

—

Nonorganic sleeping disorders

1.25

0.20

1.0

1.1

—

Fever of other and unknown origin

0.81

0.20

1.2

1.1

—

External causes of morbidity and mortality

105

0.86

0.20

1.1

—

Pain (limb, back, neck, head abdominally)

0.84

0.20

1.0

1.1

—

Asthma, including avohilmo

147

0.88

0.20

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.21

0.19

1.2

1.1

—

Sleep disorders (combined)

137

0.88

0.19

1.0

1.1

—

Injuries to the wrist and hand

151

0.87

0.19

1.1

—

LSIL lesion of the cervix uteri, vagina or vulva

1.21

0.18

1.1

—

All dysplastic lesions of the cervix uteri

127

1.17

0.18

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.17

0.17

1.1

—

Unspecified fall

1.15

0.17

1.1

—

Other external causes of accidental injury

114

0.88

0.17

1.1

—

Endometriosis ASRM stages 1,2

1.13

0.17

1.0

1.1

—

Other pulmonary diagnosis

1.14

0.17

1.0

1.1

—

Certain infectious and parasitic diseases

1.16

0.17

1.1

—

Other viral diseases, not elsewhere classified

1.12

0.17

1.1

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.73

0.17

1.0

—

Viral infections characterized by skin and mucous membrane lesions

0.75

0.17

1.0

1.1

—

Anxiety disorders

143

0.88

0.17

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

143

0.88

0.16

1.0

1.1

—

Hypothyroidism (congenital or acquired)

0.85

0.16

1.0

1.1

—

Urticaria

1.11

0.16

1.0

1.1

—

Dental operations

1.16

0.16

1.0

1.1

—

Childhood asthma (age<16)

1.21

0.15

1.0

1.1

—

Childhood asthma (age<16), excluding more controls

1.21

0.15

1.0

1.1

—

Other and unspecified tonsillitis

109

1.16

0.15

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

128

1.15

0.15

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.76

0.15

1.0

1.1

—

Fracture of forearm

1.20

0.15

1.2

1.1

—

Impacted teeth

1.17

0.15

1.1

1.0

—

Injury, poisoning and certain other consequences of external causes

0.88

0.15

1.1

—

Injuries to the elbow and forearm

123

0.86

0.15

1.2

1.1

—

Persons encountering health services in other circumstances

1.20

0.14

1.0

1.1

—

L04AX Other immunosuppressants

0.79

0.14

1.1

—

ILD medications

144

0.90

0.14

1.0

1.1

—

Other heart diseases

0.79

0.14

1.0

1.1

—

Hypothyroidism, strict autoimmune

126

0.89

0.13

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

146

0.90

0.13

1.1

—

Anaemias

0.82

0.13

1.0

1.1

—

Intracranial injury

102

0.83

0.13

1.0

1.1

—

Asthma, hospital admission 2, infections

105

0.84

0.13

1.1

1.0

—

Asthma-related infections

105

0.84

0.13

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

134

1.08

0.11

1.1

—

Anxiety (asthma-related co-morbidities)

138

0.90

0.11

1.1

—

Other viral diseases

104

1.14

0.11

1.1

—

Other diseases of urinary system

135

0.92

0.10

1.1

—

Complications of procedures, not elsewhere classified

121

0.89

0.10

1.0

1.1

—

124

1.08

0.10

1.1

—

Irregular menses

148

0.91

0.10

1.0

1.1

—

Fracture of foot, except ankle

1.09

0.09

1.0

1.1

—

Coxibs

1.05

0.09

1.0

1.2

—

Inflammatory bowel disease, strict (require KELA)

1.06

0.09

1.0

1.1

—

Epilepsy

1.06

0.09

1.2

1.1

—

Other diseases of upper respiratory tract

119

0.92

0.09

1.0

1.1

—

Zoster [herpes zoster]

1.05

0.09

1.0

1.1

—

IBD patients in KELA-register

1.04

0.09

1.0

1.1

—

Other and unspecified iron deficiency

1.04

0.09

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

137

0.92

0.09

1.0

1.1

—

Diseases of the ear and mastoid process

140

0.93

0.09

1.0

1.1

—

Accidents

114

0.92

0.08

1.0

1.1

—

Polyp of the female genital tract

0.80

0.08

1.2

1.1

—

Nonorganic sleeping disorders, excluding more controls

1.03

0.08

1.0

1.1

—

Inflammatory bowel disease

1.03

0.08

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

1.08

0.08

1.0

1.1

—

ILD differential diagnosis

1.08

0.08

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.83

0.08

1.0

1.1

—

In situ neoplasms

0.82

0.08

1.0

1.1

—

Internal derangement of knee

0.82

0.08

1.0

1.1

—

Covid-19 suspected case

0.79

0.08

1.0

1.1

—

Irritable bowel syndrome

0.79

0.08

1.0

1.1

—

KRA_PSY_EATING, excluding more controls

0.79

0.08

1.0

1.1

—

Acute appendicitis, no complications

126

1.11

0.08

1.1

—

Pain, not elsewhere classified

0.77

0.08

1.0

1.1

—

Hypothyroidism, other/unspecified

142

0.93

0.08

1.1

—

Viral and other specified intestinal infections

1.05

0.08

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.03

0.08

1.0

1.1

—

Cardiovascular diseases

136

1.07

0.07

1.0

1.1

—

Other/unspecified dorsalgia

1.02

0.07

1.0

1.1

—

Acute appendicitis

137

1.09

0.07

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.05

0.07

1.1

—

Migraine without aura and triptan purchases

0.87

0.07

1.0

1.1

—

Noninfective enteritis and colitis

0.84

0.07

1.0

1.1

—

Other and unspecified dermatitis

0.82

0.07

1.0

1.1

—

Arthropathies

140

0.94

0.07

1.1

—

Asthma, hospital admissions , main diagnosis only

147

1.08

0.07

1.1

—

Urticaria and erythema

1.02

0.07

1.0

1.1

—

COPD differential diagnosis

1.07

0.06

1.0

1.1

—

Mood disorders

145

0.94

0.06

1.0

1.1

—

Mood [affective] disorders

145

0.94

0.06

1.0

1.1

—

Infections of the skin and subcutaneous tissue

108

1.10

0.06

1.0

1.1

—

Dorsopathies

135

1.05

0.05

1.0

1.1

—

Asthma (only as main-diagnosis)

1.07

0.05

1.1

—

Postpartum haemorrhage due to retained placenta

1.11

0.05

1.1

—

Diseases of the respiratory system

1.07

0.05

1.1

—

Hypothyroidism and >3 levothyroxin purchases

0.92

0.05

1.0

1.1

—

Hypothyroidism, levothyroxine purchases

0.92

0.05

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

120

1.05

0.05

1.0

1.1

—

Chronic diseases of tonsils and adenoids

119

1.06

0.05

1.0

1.1

—

All anxiety disorders

143

0.94

0.04

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

127

0.92

0.04

1.0

1.1

—

Asthma (only as main-diagnosis), excluding more controls

1.06

0.04

1.1

—

Acute suppurative otitis media

111

0.92

0.03

1.0

1.1

—

First line medication for Crohn's disease

141

0.96

0.03

1.1

—

Codes for special purposes

121

1.07

0.03

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

121

1.07

0.03

1.0

1.1

—

Bronchitis

145

0.96

0.03

1.0

1.1

—

Autoimmune diseases

132

1.04

0.03

1.0

1.1

—

Disorders of the thyroid gland

143

0.96

0.03

1.0

1.1

—

Appendicitis, broad definition

137

1.06

0.03

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

127

1.05

0.02

1.1

—

Exposure to unspecified factor

150

0.96

0.02

1.1

—

Diseases of appendix

137

1.05

0.02

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

129

0.96

0.02

1.0

1.1

—

Any gastric operation

116

1.04

0.02

1.0

1.1

—

GASTRO-related operations

116

1.04

0.02

1.0

1.1

—

Obesity due to excess calories

117

0.94

0.01

1.1

—

Excessive attrition of teeth

133

1.05

0.01

1.1

—

Transport accidents

109

0.95

0.01

1.2

1.1

—

Cystitis

135

0.97

0.01

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

131

1.03

0.01

1.1

—

Triptan medication for migraine, single purchase ok

131

1.03

0.01

1.1

—

Vasomotor and allergic rhinitis

104

0.94

0.00

1.0

1.1

—

Used for control exclusion in common control thyroid runs

128

1.03

0.00

1.0

1.1

—

Complications of medical and surgical care

105

1.05

0.00

1.1

—

Depression

145

1.03

0.00

1.0

1.1

—

Asthma, excluding more controls

0.97

0.00

1.1

—

Dermatophytosis

101

0.99

0.00

1.0

1.1

—

Acute sinusitis

120

1.00

0.00

1.0

1.1

—

Other dorsopathies, not elsewhere classified

135

1.01

0.00

1.0

1.1

—

Recurrent or chronic depression

1.00

0.00

1.0

1.1

—

Benign neoplasms

142

1.01

0.00

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

150

1.02

0.00

1.1

—

Nonsuppurative otitis media

0.96

0.00

1.0

1.1

—

Asthma

0.97

0.00

1.1

—

Endometriosis

0.99

0.00

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

152

1.01

0.00

1.0

1.1

—

Suppurative and unspecified otitis media

125

0.99

0.00

1.0

1.1

—

Asthma (mode)

0.99

0.00

1.1

—

HSIL lesion of the cervix uteri

1.01

0.00

1.0

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

101

0.99

0.00

1.0

1.1

—

Malignant neoplasm of cervix uteri, including Hilmo

0.00

0.0

1.0

—

Enterocolitis due to Clostridium difficile

0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.93

0.00

1.0

1.1

—

Contact with heat and hot substances

0.00

0.0

1.1

—

Cluster headache, wide

0.00

0.0

1.0

—

Psoriatic arthropathies, ICD10

0.00

0.0

1.0

—

Disorders of parathyroid gland

0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.0

—

Abnormal findings on examination of urine, without diagnosis

0.00

0.0

1.0

—

Golimumab

0.00

0.0

1.0

—

Sicca syndrome [Sjögren]

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.0

—

Nontoxic single thyroid nodule

0.00

0.0

1.0

—

Cholecystitis

0.00

0.0

1.0

—

Wide developmental disorders

0.00

0.0

1.2

—

Disorders of choroid and retina

0.93

0.00

1.2

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

0.0

1.0

—

Other and/or unspecified nontoxic goitre

0.00

0.0

1.0

—

Panniculitis affecting regions of neck and back

0.00

0.0

1.0

—

Hypermetropia

0.00

0.0

1.1

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

0.0

1.0

—

Other and unspecified iridocyclitis

0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.0

—

6-mercaptopurine

0.00

0.0

1.1

—

Other orthopaedic follow-up care

0.00

0.0

1.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.0

1.0

—

Perioral dermatitis

0.00

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

0.0

1.1

—

0.00

0.0

1.2

—

Benign neoplasm of mouth and pharynx

0.00

-0.00

0.0

1.0

—

Other infectious diseases

0.00

-0.00

0.0

1.0

—

Effects of other external causes

0.00

-0.00

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

-0.00

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

1.0

—

All-cause Heart Failure

0.00

-0.00

0.0

1.0

—

Other disorders of white blood cells

0.00

-0.00

0.0

1.0

—

Achilles tendinitis

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.1

—

Varicella [chickenpox]

0.00

-0.00

0.0

1.2

—

Focal brain injury

0.00

-0.00

0.0

1.0

—

Dystonia

0.00

-0.00

0.0

1.0

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

1.0

—

Autism

0.00

-0.00

0.0

1.2

—

Vertical strabismus

0.00

-0.00

0.0

1.0

—

Allergic asthma (mode), excluding more controls

0.99

-0.00

1.1

—

Viral meningitis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

1.0

—

Continuous positive airway pressure

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Colon, unspecified

0.00

-0.00

0.0

1.0

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.0

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.2

—

Sequelae of injuries of head

0.00

-0.00

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.00

-0.00

0.0

1.0

—

Toxic effect of contact with venomous animals

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the urinary system

0.00

-0.00

0.0

1.0

—

Visual field defects

0.00

-0.00

0.0

1.0

—

Amblyopia ex anopsia

0.00

-0.00

0.0

1.2

—

Other peripheral vertigo

0.00

-0.00

0.0

1.0

—

Heart failure, strict

0.00

-0.00

0.0

1.0

—

Acute bronchiolitis

0.00

-0.00

0.0

1.1

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

-0.00

0.0

1.0

—

Neuralgia and neuritis, unspecified

0.00

-0.00

0.0

1.0

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.0

—

Burn and corrosion of wrist and hand

0.00

-0.00

0.0

1.0

—

Insulin medication

0.92

-0.00

1.0

1.1

—

Acute renal failure

0.00

-0.00

0.0

1.0

—

Eating disorder

0.98

-0.00

1.0

1.1

—

Abnormal weight loss

0.00

-0.00

0.0

1.1

—

Abnormal findings on diagnostic imaging of central nervous system

0.00

-0.00

0.0

1.0

—

Cramp and spasm

0.00

-0.00

0.0

1.0

—

L04AC Interleukin inhibitors

0.00

-0.00

0.0

1.0

—

Allergic asthma (mode)

0.99

-0.00

1.1

—

Obstructed labour due to maternal pelvic abnormality

0.00

-0.00

0.0

1.3

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.95

-0.00

1.0

1.1

—

Other psoriatic arthropathies

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.2

—

Mixed disorders of conduct and emotions

0.00

-0.00

0.0

1.3

—

Hypo-osmolality and hyponatraemia

0.00

-0.00

0.0

1.0

—

Hypokalaemia

0.00

-0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

-0.00

0.0

1.2

—

Spirochaetal infections, other/unspecified

0.00

-0.00

0.0

1.0

—

Coxarthrosis, primary

0.00

-0.00

0.0

1.0

—

Hypoglycaemia, other or unspecified

0.00

-0.00

0.0

1.0

—

Secondary uncertain malignant neoplasm

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.2

—

Scabies

0.00

-0.00

0.0

1.1

—

Periapical abscess

0.91

-0.00

1.0

1.1

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

1.2

—

Hypopituitarism

0.00

-0.00

0.0

1.0

—

Colectomy operation

0.00

-0.00

0.0

1.0

—

Other disorders of bladder

0.00

-0.00

0.0

1.0

—

Open wound of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.2

—

Subacute thyroiditis

0.00

-0.00

0.0

1.0

—

Adhesive capsulitis of shoulder

0.00

-0.00

0.0

1.0

—

Psoriatic arthropathies

0.00

-0.00

0.0

1.0

—

Sciatica+with lumbago

0.93

-0.00

1.0

1.1

—

Nonspecific lymphadenitis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.0

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

-0.00

0.0

1.0

—

Superficial injury of neck

0.00

-0.00

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

1.0

—

Other infectious diseases

0.00

-0.00

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.0

—

Episcleritis

0.00

-0.00

0.0

1.0

—

Primary ovarian failure

0.00

-0.00

0.0

1.0

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

-0.00

0.0

1.0

—

Artificial joint operation, meniscal resection

0.98

-0.00

1.4

1.1

—

Other diseases of arteries and capillaries

0.00

-0.00

0.0

1.0

—

Ehlers-Danlos syndrome

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders of vitreous body

0.00

-0.00

0.0

1.0

—

Cerebral aneurysm, nonruptured

0.00

-0.00

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

-0.00

0.0

1.0

—

Chronic sinusitis

0.89

-0.00

1.0

1.1

—

Crossbite

0.00

-0.00

0.0

1.1

—

Chronic viral hepatitis

0.00

-0.00

0.0

1.0

—

Adrenocortical insufficiency

0.00

-0.00

0.0

1.0

—

Invasive ventilation

0.00

-0.00

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

-0.00

0.0

1.0

—

Sequelae of cerebrovascular disease

0.00

-0.00

0.0

1.0

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

0.00

-0.00

0.0

1.0

—

Tooth eruption problems

0.86

-0.00

1.0

1.1

—

Lichen sclerosus et atrophicus

0.00

-0.00

0.0

1.0

—

Dermatitis due to substances taken internally

0.00

-0.00

0.0

1.1

—

Autism spe

0.00

-0.00

0.0

1.2

—

Abscess of Bartholin gland

0.00

-0.00

0.0

1.0

—

Seborrhoeic keratosis

0.00

-0.00

0.0

1.0

—

Use of interferon beta-1a

0.00

-0.00

0.0

1.0

—

Varicella [chickenpox]

0.00

-0.00

0.0

1.1

—

Mandibular retrognathia AND surgery (BSSO)

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the vulva

0.00

-0.00

0.0

1.0

—

All dysplastic lesions of the vagina

0.00

-0.00

0.0

1.0

—

Use of glatiramer acetate

0.00

-0.00

0.0

1.0

—

Sacrococcygeal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Organic, including symptomatic, mental disorders

0.00

-0.00

0.0

1.0

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.0

—

Erosion of teeth , including avohilmo

0.88

-0.00

1.0

1.1

—

Cluster headache, strict

0.00

-0.00

0.0

1.0

—

Eating disorders

0.96

-0.00

1.0

1.1

—

Diseases of the myoneural junction and muscle

0.00

-0.00

0.0

1.0

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

-0.00

0.0

1.3

—

Disorders of mineral metabolism

0.00

-0.00

0.0

1.0

—

Wide developmental disorders, excluding more controls

0.00

-0.00

0.0

1.3

—

Cardiomyopathy

0.00

-0.00

0.0

1.0

—

Malignant melanoma

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

Inflammatory diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Meningitis

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.0

—

Convalescence

0.00

-0.00

0.0

1.0

—

Herpesviral [herpes simplex] infections

0.91

-0.00

1.0

1.1

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Viral and other specified intestinal infections

0.90

-0.00

1.0

1.1

—

Autism spe, excluding more controls

0.00

-0.00

0.0

1.3

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

-0.00

0.0

1.0

—

Aneurysms, operations, SAH

0.00

-0.00

0.0

1.0

—

Car occupant injured in noncollision transport accident

0.00

-0.00

0.0

1.2

—

Hyperprolactinaemia

0.00

-0.00

0.0

1.1

—

Other specified/unspecified bacterial intestinal infections

0.00

-0.00

0.0

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.91

-0.00

1.1

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

-0.00

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

1.0

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

1.1

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

1.0

—

Congenital malformations of the nervous system

0.00

-0.00

0.0

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.00

-0.00

1.0

1.1

—

Glomerulonephritis

0.00

-0.00

0.0

1.0

—

Allergic rhinitis

0.91

-0.00

1.0

1.1

—

Foreign body entering into or through eye or natural orifice

0.00

-0.00

0.0

1.1

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

1.0

—

Exposure to other specified electric current

0.00

-0.00

0.0

1.0

—

Impetigo

0.00

-0.00

0.0

1.1

—

Pollen allergy

0.90

-0.00

1.0

1.1

—

Use of disulfiram, acamprosate or naltrexone

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

-0.00

0.0

1.0

—

Sequelae of other external causes

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.0

—

Heart failure,strict

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of head

0.00

-0.00

0.0

1.0

—

Malignant melanoma, including Hilmo

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of wrist and hand

0.00

-0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.0

—

Other obstructive and reflux uropathy

0.00

-0.00

0.0

1.0

—

Injury of unspecified body region

0.00

-0.00

0.0

1.1

—

SLE (Finngen)

0.00

-0.00

0.0

1.0

—

Acute generalized exanthematous pustulosis

0.00

-0.00

0.0

1.0

—

Other and unspecified follicular disorders

0.00

-0.00

0.0

1.0

—

Disorders of orbit

0.00

-0.00

0.0

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

-0.00

0.0

1.0

—

Congenital malformations of uterus and cervix

0.00

-0.00

0.0

1.0

—

Galactorrhea

0.00

-0.00

0.0

1.0

—

Papillary adenocarcinoma of thyroid gland

0.00

-0.00

0.0

1.0

—

Toxic effect of ethanol

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

1.0

—

Ingrowing nail

0.00

-0.00

0.0

1.0

—

Other inflammatory liver diseases

0.00

-0.00

0.0

1.0

—

Generalized skin eruption due to drugs and medicaments

0.00

-0.00

0.0

1.0

—

Hyperhidrosis

0.00

-0.00

0.0

1.0

—

Vitamin deficiency

0.00

-0.00

0.0

1.0

—

Vitamin deficiency, wide

0.00

-0.00

0.0

1.0

—

Other bursopathies

0.00

-0.00

0.0

1.0

—

Arthropathic psoriasis

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Chromosome analysis panel - Chorionic villus sample by G-banded

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS